Michael E. Kamarck - 25 May 2023 Form 4 Insider Report for Passage BIO, Inc. (PASG)

Role
Director
Signature
/s/ Edgar Cale, Attorney-in-Fact
Issuer symbol
PASG
Transactions as of
25 May 2023
Net transactions value
$0
Form type
4
Filing time
26 May 2023, 16:31:58 UTC
Previous filing
06 Jul 2022
Next filing
15 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PASG Director Stock Option (Right to Buy) Award $0 +21,567 $0.000000 21,567 25 May 2023 Common Stock 21,567 $1.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2024 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date.